XML 55 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Schedule of Segment Performance The following is a summary of segment performance:
(in thousands)For the Three Months Ended September 30,
CAGWaterLPDOtherConsolidated Total
2023
Revenue$837,160 $44,450 $29,747 $4,170 $915,527 
Income from operations$253,358 $20,328 $2,405 $(808)$275,283 
Interest expense, net(7,392)
Income before provision for income taxes267,891 
Provision for income taxes55,660 
Net income attributable to IDEXX Laboratories, Inc. stockholders$212,231 
2022
Revenue$764,990 $40,840 $28,452 $7,379 $841,661 
Income from operations$221,454 $19,924 $4,480 $(1,030)$244,828 
Interest expense, net(10,645)
Income before provision for income taxes234,183 
Provision for income taxes53,245 
Net income attributable to IDEXX Laboratories, Inc. stockholders$180,938 
(in thousands)For the Nine Months Ended September 30,
CAGWaterLPDOtherConsolidated Total
2023
Revenue$2,531,091 $126,362 $88,866 $13,033 $2,759,352 
Income from operations$790,617 $57,119 $5,664 $(1,574)$851,826 
Interest expense, net(30,318)
Income before provision for income taxes821,508 
Provision for income taxes170,987 
Net income attributable to IDEXX Laboratories, Inc. stockholders$650,521 
2022
Revenue$2,310,261 $116,406 $89,211 $22,878 $2,538,756 
Income from operations$601,105 $54,498 $14,447 $2,188 $672,238 
Interest expense, net(25,481)
Income before provision for income taxes646,757 
Provision for income taxes139,875 
Net income attributable to IDEXX Laboratories, Inc. stockholders$506,882